Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Asset Utilization Ratio (2021 - 2023)

Historic Asset Utilization Ratio for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to 143.4.

  • ADC Therapeutics' Asset Utilization Ratio rose 5374032.73% to 143.4 in Q3 2023 from the same period last year, while for Sep 2023 it was 143.4, marking a year-over-year increase of 5374032.73%. This contributed to the annual value of 0.0 for FY2022, which is N/A changed from last year.
  • ADC Therapeutics' Asset Utilization Ratio amounted to 143.4 in Q3 2023, which was up 5374032.73% from 143.41 recorded in Q2 2023.
  • ADC Therapeutics' 5-year Asset Utilization Ratio high stood at 145.87 for Q1 2023, and its period low was 0.0 during Q1 2021.
  • In the last 4 years, ADC Therapeutics' Asset Utilization Ratio had a median value of 0.2 in 2022 and averaged 47.53.
  • Per our database at Business Quant, ADC Therapeutics' Asset Utilization Ratio plummeted by 9074.43% in 2021 and then skyrocketed by 45630321.04% in 2022.
  • ADC Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.33 in 2020, then plummeted by 90.96% to 0.03 in 2021, then surged by 456303.21% to 136.78 in 2022, then increased by 4.84% to 143.4 in 2023.
  • Its Asset Utilization Ratio stands at 143.4 for Q3 2023, versus 143.41 for Q2 2023 and 145.87 for Q1 2023.